Motif ID: Snai1_Zeb1_Snai2
Z-value: 2.055
Transcription factors associated with Snai1_Zeb1_Snai2:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Snai1 | ENSMUSG00000042821.7 | Snai1 |
| Snai2 | ENSMUSG00000022676.6 | Snai2 |
| Zeb1 | ENSMUSG00000024238.7 | Zeb1 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Zeb1 | mm10_v2_chr18_+_5591860_5591902 | -0.69 | 6.4e-09 | Click! |
| Snai1 | mm10_v2_chr2_+_167538192_167538210 | 0.16 | 2.4e-01 | Click! |
| Snai2 | mm10_v2_chr16_+_14705832_14705858 | -0.10 | 4.9e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.8 | 23.5 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 5.2 | 15.5 | GO:0099548 | trans-synaptic signaling by nitric oxide(GO:0099548) |
| 4.6 | 13.8 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 4.2 | 24.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 4.1 | 28.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 3.9 | 11.7 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 3.9 | 15.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 3.8 | 26.6 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 3.3 | 13.1 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 3.2 | 9.6 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 3.1 | 9.4 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 3.1 | 12.2 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 3.0 | 11.9 | GO:0021586 | pons maturation(GO:0021586) |
| 2.9 | 8.8 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 2.8 | 8.5 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 2.8 | 8.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 2.7 | 5.5 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
| 2.7 | 24.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 2.7 | 8.0 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 2.6 | 10.6 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 2.6 | 2.6 | GO:1902667 | regulation of axon guidance(GO:1902667) |
| 2.5 | 2.5 | GO:1904809 | dense core granule localization(GO:0032253) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
| 2.4 | 7.2 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 2.4 | 14.1 | GO:0032796 | uropod organization(GO:0032796) |
| 2.2 | 6.6 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 2.2 | 6.6 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
| 2.2 | 8.8 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 2.1 | 8.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 2.1 | 6.4 | GO:0060596 | mammary placode formation(GO:0060596) |
| 2.1 | 12.8 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 2.1 | 6.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 2.1 | 12.6 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 2.1 | 14.6 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 2.0 | 2.0 | GO:0050810 | regulation of steroid biosynthetic process(GO:0050810) |
| 2.0 | 6.0 | GO:0007172 | signal complex assembly(GO:0007172) |
| 2.0 | 11.9 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 2.0 | 5.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 2.0 | 9.9 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 2.0 | 2.0 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
| 2.0 | 13.8 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 1.9 | 23.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.9 | 5.7 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 1.9 | 9.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.9 | 5.6 | GO:0051715 | cytolysis in other organism(GO:0051715) |
| 1.8 | 8.9 | GO:1902287 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 1.8 | 17.8 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 1.7 | 13.9 | GO:0051014 | actin filament severing(GO:0051014) |
| 1.7 | 5.2 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 1.7 | 5.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 1.7 | 5.2 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 1.7 | 3.4 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 1.7 | 5.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 1.7 | 6.7 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 1.7 | 5.0 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 1.7 | 6.6 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 1.6 | 6.5 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 1.6 | 4.8 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 1.6 | 4.7 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
| 1.5 | 1.5 | GO:0060003 | copper ion export(GO:0060003) |
| 1.5 | 4.6 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 1.5 | 9.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 1.5 | 4.5 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 1.5 | 3.0 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
| 1.5 | 4.4 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 1.5 | 11.8 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 1.5 | 3.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 1.5 | 4.4 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 1.4 | 4.3 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 1.4 | 7.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 1.4 | 7.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 1.4 | 8.3 | GO:0097646 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 1.4 | 4.1 | GO:0043181 | vacuolar sequestering(GO:0043181) |
| 1.4 | 5.5 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 1.4 | 4.1 | GO:1903002 | positive regulation of low-density lipoprotein particle receptor catabolic process(GO:0032805) regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
| 1.4 | 8.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 1.4 | 8.2 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 1.4 | 9.5 | GO:0019532 | oxalate transport(GO:0019532) |
| 1.4 | 9.5 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 1.3 | 8.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 1.3 | 6.7 | GO:0099612 | protein localization to axon(GO:0099612) |
| 1.3 | 13.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 1.3 | 4.0 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.3 | 6.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
| 1.3 | 10.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.3 | 2.6 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 1.3 | 31.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 1.3 | 11.7 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 1.3 | 5.2 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 1.3 | 2.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 1.3 | 7.7 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 1.3 | 11.5 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 1.3 | 3.8 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
| 1.3 | 1.3 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 1.3 | 7.6 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 1.2 | 6.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 1.2 | 3.7 | GO:0071873 | response to norepinephrine(GO:0071873) |
| 1.2 | 2.4 | GO:0042092 | type 2 immune response(GO:0042092) |
| 1.2 | 3.6 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 1.2 | 10.8 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
| 1.2 | 3.6 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 1.2 | 1.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
| 1.2 | 5.9 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
| 1.2 | 2.4 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.2 | 7.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 1.2 | 2.3 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 1.2 | 7.0 | GO:0097117 | guanylate kinase-associated protein clustering(GO:0097117) |
| 1.1 | 1.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 1.1 | 6.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 1.1 | 6.8 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 1.1 | 2.3 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
| 1.1 | 5.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 1.1 | 7.9 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 1.1 | 12.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 1.1 | 12.0 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 1.1 | 4.4 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 1.1 | 5.4 | GO:0042701 | progesterone secretion(GO:0042701) |
| 1.1 | 7.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 1.1 | 2.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 1.1 | 1.1 | GO:1904347 | intestine smooth muscle contraction(GO:0014827) regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) regulation of small intestine smooth muscle contraction(GO:1904347) small intestine smooth muscle contraction(GO:1990770) |
| 1.1 | 15.1 | GO:0001553 | luteinization(GO:0001553) |
| 1.1 | 4.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
| 1.1 | 4.3 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 1.1 | 4.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 1.1 | 2.1 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
| 1.1 | 4.3 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 1.1 | 8.5 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
| 1.1 | 3.2 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
| 1.1 | 1.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 1.1 | 6.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 1.1 | 3.2 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 1.1 | 4.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 1.0 | 6.3 | GO:0019695 | choline metabolic process(GO:0019695) |
| 1.0 | 3.1 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 1.0 | 4.2 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
| 1.0 | 5.1 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
| 1.0 | 2.0 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
| 1.0 | 2.0 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 1.0 | 2.0 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
| 1.0 | 3.0 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
| 1.0 | 14.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 1.0 | 3.0 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 1.0 | 2.0 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
| 1.0 | 2.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 1.0 | 3.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 1.0 | 5.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 1.0 | 1.0 | GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
| 1.0 | 1.0 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 1.0 | 9.6 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 1.0 | 1.9 | GO:0002586 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.0 | 2.9 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.9 | 1.9 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
| 0.9 | 1.9 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.9 | 1.9 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.9 | 12.0 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
| 0.9 | 7.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.9 | 1.9 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
| 0.9 | 6.4 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.9 | 2.8 | GO:0042636 | negative regulation of hair cycle(GO:0042636) negative regulation of hair follicle development(GO:0051799) |
| 0.9 | 1.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.9 | 5.4 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.9 | 2.7 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.9 | 20.3 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
| 0.9 | 2.6 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.9 | 0.9 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.9 | 7.7 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.8 | 10.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.8 | 10.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.8 | 0.8 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.8 | 5.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.8 | 1.7 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.8 | 13.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.8 | 2.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.8 | 9.1 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.8 | 5.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.8 | 5.0 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
| 0.8 | 3.3 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 0.8 | 5.7 | GO:0015824 | proline transport(GO:0015824) |
| 0.8 | 2.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.8 | 1.6 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.8 | 2.4 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
| 0.8 | 3.2 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
| 0.8 | 2.4 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.8 | 1.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.8 | 16.5 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.8 | 5.5 | GO:0033034 | positive regulation of neutrophil apoptotic process(GO:0033031) positive regulation of myeloid cell apoptotic process(GO:0033034) |
| 0.8 | 1.6 | GO:0002339 | B cell selection(GO:0002339) |
| 0.8 | 0.8 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.8 | 5.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.8 | 10.0 | GO:0071625 | vocalization behavior(GO:0071625) |
| 0.8 | 3.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.8 | 13.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.8 | 0.8 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
| 0.8 | 2.3 | GO:0010958 | regulation of amino acid import(GO:0010958) |
| 0.8 | 4.6 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.8 | 3.8 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.8 | 1.5 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.7 | 1.5 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.7 | 5.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.7 | 7.4 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.7 | 3.0 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.7 | 1.5 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
| 0.7 | 11.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.7 | 2.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.7 | 1.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.7 | 2.2 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
| 0.7 | 2.9 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
| 0.7 | 0.7 | GO:1903011 | negative regulation of bone development(GO:1903011) |
| 0.7 | 4.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.7 | 3.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.7 | 5.6 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.7 | 0.7 | GO:0032439 | endosome localization(GO:0032439) |
| 0.7 | 2.8 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.7 | 2.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 0.7 | 2.1 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.7 | 2.8 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.7 | 0.7 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
| 0.7 | 1.4 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.7 | 1.4 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
| 0.7 | 4.1 | GO:1903056 | mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.7 | 2.7 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.7 | 3.4 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.7 | 6.8 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.7 | 0.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.7 | 2.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.7 | 4.7 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 0.7 | 11.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.7 | 3.3 | GO:0015871 | choline transport(GO:0015871) |
| 0.7 | 3.9 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.7 | 4.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.6 | 1.9 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.6 | 2.6 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.6 | 4.5 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
| 0.6 | 7.7 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.6 | 2.5 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) |
| 0.6 | 1.3 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.6 | 1.9 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.6 | 2.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.6 | 0.6 | GO:0071280 | cellular response to copper ion(GO:0071280) |
| 0.6 | 4.4 | GO:0015862 | uridine transport(GO:0015862) |
| 0.6 | 1.9 | GO:0014889 | muscle atrophy(GO:0014889) |
| 0.6 | 3.8 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.6 | 3.1 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.6 | 1.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.6 | 8.0 | GO:1901898 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.6 | 1.2 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.6 | 10.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.6 | 4.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.6 | 2.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.6 | 0.6 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.6 | 15.7 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.6 | 1.8 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.6 | 1.2 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.6 | 1.2 | GO:2000851 | positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.6 | 7.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.6 | 2.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.6 | 3.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.6 | 1.8 | GO:0061744 | motor behavior(GO:0061744) |
| 0.6 | 8.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.6 | 1.8 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.6 | 4.7 | GO:0032274 | gonadotropin secretion(GO:0032274) |
| 0.6 | 1.7 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.6 | 2.3 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.6 | 4.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.6 | 1.2 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
| 0.6 | 2.9 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.6 | 2.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
| 0.6 | 1.7 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.6 | 0.6 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.6 | 2.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.6 | 8.4 | GO:0010543 | regulation of platelet activation(GO:0010543) |
| 0.6 | 0.6 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.6 | 3.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.6 | 8.3 | GO:0045056 | transcytosis(GO:0045056) |
| 0.5 | 1.6 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.5 | 0.5 | GO:0048143 | astrocyte activation(GO:0048143) |
| 0.5 | 1.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.5 | 2.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.5 | 5.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.5 | 3.8 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.5 | 3.3 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.5 | 1.6 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.5 | 2.2 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.5 | 0.5 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.5 | 1.6 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.5 | 23.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.5 | 1.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.5 | 22.0 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.5 | 2.1 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.5 | 0.5 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.5 | 2.6 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.5 | 8.5 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.5 | 0.5 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.5 | 1.6 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 0.5 | 0.5 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 0.5 | 4.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.5 | 1.0 | GO:0001821 | histamine secretion(GO:0001821) |
| 0.5 | 3.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.5 | 1.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.5 | 1.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.5 | 1.5 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
| 0.5 | 2.5 | GO:0046541 | saliva secretion(GO:0046541) |
| 0.5 | 1.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.5 | 3.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.5 | 2.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.5 | 0.5 | GO:0010820 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
| 0.5 | 3.4 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 0.5 | 2.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.5 | 1.5 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.5 | 1.0 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.5 | 1.4 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.5 | 3.4 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
| 0.5 | 3.8 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.5 | 1.4 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 0.5 | 14.9 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.5 | 1.4 | GO:0072143 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.5 | 2.8 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.5 | 1.9 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) regulation of collateral sprouting in absence of injury(GO:0048696) |
| 0.5 | 1.4 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
| 0.5 | 1.9 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.5 | 1.9 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.5 | 5.1 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.5 | 0.5 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.5 | 9.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.5 | 2.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.5 | 0.9 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 0.5 | 1.4 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.5 | 1.4 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
| 0.5 | 0.5 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.5 | 4.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.5 | 1.4 | GO:0006507 | GPI anchor release(GO:0006507) |
| 0.4 | 14.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
| 0.4 | 4.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
| 0.4 | 0.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.4 | 12.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.4 | 1.3 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.4 | 5.3 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.4 | 0.9 | GO:0035106 | operant conditioning(GO:0035106) |
| 0.4 | 0.9 | GO:0010847 | regulation of chromatin assembly(GO:0010847) negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.4 | 2.2 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.4 | 4.8 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.4 | 0.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.4 | 31.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.4 | 2.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.4 | 1.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.4 | 2.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.4 | 1.3 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
| 0.4 | 3.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.4 | 1.3 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
| 0.4 | 0.4 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
| 0.4 | 2.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.4 | 1.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.4 | 0.8 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.4 | 0.8 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.4 | 1.7 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.4 | 1.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.4 | 0.8 | GO:0097061 | dendritic spine organization(GO:0097061) |
| 0.4 | 1.6 | GO:0006848 | pyruvate transport(GO:0006848) |
| 0.4 | 1.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.4 | 2.8 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.4 | 1.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
| 0.4 | 13.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.4 | 1.2 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.4 | 3.2 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.4 | 0.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.4 | 0.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.4 | 3.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.4 | 0.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.4 | 1.2 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
| 0.4 | 1.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.4 | 6.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.4 | 3.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.4 | 10.3 | GO:0051693 | actin filament capping(GO:0051693) |
| 0.4 | 2.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.4 | 3.4 | GO:0033572 | transferrin transport(GO:0033572) |
| 0.4 | 3.8 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.4 | 3.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.4 | 1.9 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.4 | 1.9 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.4 | 1.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.4 | 0.4 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.4 | 0.7 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 0.4 | 4.0 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.4 | 0.4 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.4 | 1.1 | GO:0090646 | mitochondrial RNA 3'-end processing(GO:0000965) mitochondrial tRNA processing(GO:0090646) |
| 0.4 | 0.4 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.4 | 1.4 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.4 | 4.0 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.4 | 0.7 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.4 | 4.3 | GO:0045061 | thymic T cell selection(GO:0045061) |
| 0.4 | 2.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.4 | 1.1 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.4 | 0.7 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.4 | 8.2 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.4 | 0.7 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.4 | 2.5 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.4 | 0.7 | GO:0015866 | ADP transport(GO:0015866) |
| 0.4 | 2.5 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.4 | 2.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.4 | 3.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.4 | 2.5 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.4 | 1.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.3 | 2.1 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
| 0.3 | 1.0 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
| 0.3 | 1.7 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
| 0.3 | 0.7 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.3 | 4.9 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.3 | 2.4 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
| 0.3 | 3.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
| 0.3 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.3 | 1.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.3 | 1.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.3 | 3.8 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.3 | 0.3 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.3 | 1.0 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.3 | 1.0 | GO:0002931 | response to ischemia(GO:0002931) |
| 0.3 | 2.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.3 | 2.0 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.3 | 3.7 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.3 | 1.0 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.3 | 0.7 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
| 0.3 | 2.0 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) |
| 0.3 | 10.1 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.3 | 1.0 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.3 | 3.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.3 | 1.0 | GO:0070488 | neutrophil aggregation(GO:0070488) |
| 0.3 | 0.6 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.3 | 1.0 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.3 | 1.3 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.3 | 1.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.3 | 1.3 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.3 | 1.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.3 | 4.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 0.3 | 12.4 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.3 | 1.6 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
| 0.3 | 0.9 | GO:0030049 | muscle filament sliding(GO:0030049) |
| 0.3 | 0.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.3 | 3.7 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.3 | 1.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.3 | 0.9 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.3 | 1.2 | GO:0090472 | dibasic protein processing(GO:0090472) |
| 0.3 | 2.5 | GO:0001783 | B cell apoptotic process(GO:0001783) |
| 0.3 | 0.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.3 | 4.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.3 | 0.6 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.3 | 4.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
| 0.3 | 1.2 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.3 | 2.4 | GO:1903874 | ferrous iron transmembrane transport(GO:1903874) |
| 0.3 | 2.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.3 | 7.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.3 | 0.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 0.3 | 0.9 | GO:0022406 | membrane docking(GO:0022406) |
| 0.3 | 0.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.3 | 0.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.3 | 3.6 | GO:0060789 | hair follicle placode formation(GO:0060789) |
| 0.3 | 1.8 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.3 | 0.9 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.3 | 0.6 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
| 0.3 | 1.5 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.3 | 0.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 0.3 | 2.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.3 | 0.9 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.3 | 1.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.3 | 2.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.3 | 1.2 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
| 0.3 | 0.6 | GO:0045759 | negative regulation of action potential(GO:0045759) |
| 0.3 | 1.2 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
| 0.3 | 2.6 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
| 0.3 | 0.9 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.3 | 0.9 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.3 | 1.5 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.3 | 1.4 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.3 | 1.7 | GO:0001765 | membrane raft assembly(GO:0001765) |
| 0.3 | 1.2 | GO:0002158 | osteoclast proliferation(GO:0002158) |
| 0.3 | 1.7 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.3 | 1.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.3 | 0.6 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.3 | 0.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
| 0.3 | 0.9 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.3 | 7.6 | GO:0048678 | response to axon injury(GO:0048678) |
| 0.3 | 0.8 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.3 | 0.8 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.3 | 1.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.3 | 1.4 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.3 | 1.4 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.3 | 0.6 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.3 | 1.9 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.3 | 1.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.3 | 0.3 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.3 | 1.1 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.3 | 0.8 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.3 | 1.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.3 | 0.8 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.3 | 0.5 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
| 0.3 | 0.8 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.3 | 0.8 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.3 | 1.9 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.3 | 1.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.3 | 3.2 | GO:0007041 | lysosomal transport(GO:0007041) |
| 0.3 | 0.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.3 | 1.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.3 | 1.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.3 | 0.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.3 | 0.8 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
| 0.3 | 0.5 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.3 | 1.0 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.3 | 2.9 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.3 | 3.4 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.3 | 0.8 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.3 | 0.8 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.3 | 0.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.3 | 3.6 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
| 0.3 | 0.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.3 | 1.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.3 | 1.3 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
| 0.3 | 0.8 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.3 | 0.5 | GO:0007128 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
| 0.3 | 0.5 | GO:0043379 | memory T cell differentiation(GO:0043379) |
| 0.3 | 0.5 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 0.3 | 1.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.2 | 0.7 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.2 | 1.5 | GO:0008272 | sulfate transport(GO:0008272) |
| 0.2 | 1.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 | 0.5 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.2 | 1.5 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.2 | 2.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 | 1.0 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.2 | 3.2 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
| 0.2 | 2.4 | GO:0051769 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.2 | 1.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.2 | 0.2 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.2 | 0.5 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
| 0.2 | 4.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.2 | 14.3 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
| 0.2 | 0.2 | GO:0007567 | parturition(GO:0007567) |
| 0.2 | 2.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.2 | 1.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.2 | 2.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.2 | 3.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.2 | 1.4 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.2 | 1.6 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 | 3.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.2 | 1.8 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.2 | 0.7 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.2 | 0.5 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.2 | 0.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 | 1.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.2 | 1.4 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 0.2 | 0.7 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.2 | 0.4 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.2 | 1.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 0.2 | 3.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.2 | 0.4 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) sequestering of triglyceride(GO:0030730) |
| 0.2 | 3.7 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
| 0.2 | 0.7 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 0.2 | 1.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.2 | 0.9 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.2 | 2.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.2 | 1.1 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.2 | 1.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 | 1.5 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.2 | 1.5 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.2 | 0.9 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.2 | 8.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 | 2.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.2 | 3.2 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 0.2 | 0.6 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
| 0.2 | 1.5 | GO:0005980 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.2 | 5.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.2 | 1.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.2 | 0.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.2 | 0.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 | 1.7 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.2 | 2.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.2 | 1.4 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.2 | 0.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.2 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.2 | 1.0 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.2 | 0.4 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.2 | 0.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 | 1.6 | GO:0045010 | Arp2/3 complex-mediated actin nucleation(GO:0034314) actin nucleation(GO:0045010) |
| 0.2 | 0.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 | 0.4 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.2 | 2.8 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.2 | 2.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.2 | 0.6 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.2 | 2.2 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.2 | 1.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.2 | 0.6 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
| 0.2 | 1.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 | 0.2 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
| 0.2 | 1.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.2 | 1.5 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.2 | 1.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.2 | 0.4 | GO:0060594 | mammary gland specification(GO:0060594) |
| 0.2 | 3.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
| 0.2 | 0.9 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
| 0.2 | 0.2 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) |
| 0.2 | 3.0 | GO:0070528 | protein kinase C signaling(GO:0070528) |
| 0.2 | 0.7 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.2 | 0.4 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.2 | 1.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.2 | 2.0 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.2 | 0.7 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.2 | 1.7 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.2 | 1.7 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.2 | 0.7 | GO:0015786 | UDP-glucose transport(GO:0015786) |
| 0.2 | 0.2 | GO:0071285 | response to lithium ion(GO:0010226) cellular response to lithium ion(GO:0071285) |
| 0.2 | 1.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.2 | 0.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.2 | 1.1 | GO:0016236 | macroautophagy(GO:0016236) |
| 0.2 | 0.9 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.2 | 0.5 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 0.2 | 1.6 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.2 | 2.9 | GO:0008206 | bile acid metabolic process(GO:0008206) |
| 0.2 | 1.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.2 | 0.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.2 | 0.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.2 | 0.9 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.2 | 1.1 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
| 0.2 | 2.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.2 | 1.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 | 0.7 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.2 | 3.0 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
| 0.2 | 0.5 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.2 | 1.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.2 | 0.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.2 | 2.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.2 | 0.9 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.2 | 0.9 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.2 | 1.0 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.2 | 1.0 | GO:0003341 | cilium movement(GO:0003341) |
| 0.2 | 1.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.2 | 1.4 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
| 0.2 | 0.5 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.2 | 0.3 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.2 | 0.5 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.2 | 1.2 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.2 | 0.8 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.2 | 0.7 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 0.2 | 1.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.2 | 1.0 | GO:0097473 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 0.2 | 0.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
| 0.2 | 0.2 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
| 0.2 | 1.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.2 | 0.3 | GO:0090148 | membrane fission(GO:0090148) |
| 0.2 | 2.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.2 | 0.5 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
| 0.2 | 0.8 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.2 | 1.0 | GO:1901911 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.2 | 0.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.2 | 1.6 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.2 | 4.5 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.2 | 0.5 | GO:0015886 | heme transport(GO:0015886) |
| 0.2 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 0.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.2 | 3.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.2 | 0.8 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.2 | 0.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
| 0.2 | 0.5 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.2 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 | 1.1 | GO:0015879 | carnitine transport(GO:0015879) |
| 0.2 | 0.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.2 | 3.9 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.2 | 0.6 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.2 | 0.6 | GO:0097286 | iron ion import(GO:0097286) |
| 0.2 | 0.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.2 | 3.4 | GO:0034340 | response to type I interferon(GO:0034340) |
| 0.2 | 1.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.2 | 0.3 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.2 | 0.6 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.2 | 0.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 | 2.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.2 | 0.3 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
| 0.2 | 0.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.1 | 19.6 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
| 0.1 | 15.9 | GO:0016579 | protein deubiquitination(GO:0016579) |
| 0.1 | 0.3 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
| 0.1 | 0.9 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 | 1.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.1 | 2.2 | GO:0022900 | electron transport chain(GO:0022900) |
| 0.1 | 0.3 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
| 0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.1 | 1.3 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.1 | 0.9 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.1 | 1.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 | 0.7 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
| 0.1 | 1.3 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
| 0.1 | 0.6 | GO:0034243 | positive regulation of DNA-templated transcription, elongation(GO:0032786) regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.1 | 0.6 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 | 0.5 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
| 0.1 | 0.1 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.1 | 0.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 | 6.5 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 | 0.4 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.1 | 1.6 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 | 0.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.1 | 0.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 0.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 | 1.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.1 | 1.3 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.1 | 0.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 | 2.9 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.1 | 2.2 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 | 3.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 0.4 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.1 | 0.6 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 0.1 | 2.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.1 | 0.3 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
| 0.1 | 0.9 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.1 | 0.4 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 0.9 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 | 2.0 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
| 0.1 | 1.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
| 0.1 | 0.4 | GO:0060437 | lung growth(GO:0060437) |
| 0.1 | 0.6 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 | 1.9 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 0.1 | 1.2 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 | 1.6 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.1 | 8.8 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
| 0.1 | 0.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 | 0.5 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.1 | 0.2 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.1 | 0.2 | GO:1902527 | regulation of protein monoubiquitination(GO:1902525) positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 | 0.5 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.1 | 0.4 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.1 | 0.4 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.1 | 0.5 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
| 0.1 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.1 | 0.1 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.1 | 0.6 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 | 6.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.1 | 0.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.1 | 1.2 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.1 | 0.2 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.1 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 | 1.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 | 0.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 | 0.6 | GO:0006537 | glutamate biosynthetic process(GO:0006537) glutamine catabolic process(GO:0006543) |
| 0.1 | 2.3 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
| 0.1 | 1.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
| 0.1 | 0.3 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.1 | 2.1 | GO:0030317 | sperm motility(GO:0030317) |
| 0.1 | 0.7 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 | 0.8 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.1 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.1 | 0.2 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
| 0.1 | 1.6 | GO:0042407 | cristae formation(GO:0042407) |
| 0.1 | 1.1 | GO:0030041 | actin filament polymerization(GO:0030041) |
| 0.1 | 0.8 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.1 | 0.7 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 | 0.9 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
| 0.1 | 0.2 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 | 0.1 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.1 | 1.5 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.1 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.1 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 | 5.7 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.1 | 0.6 | GO:0001964 | startle response(GO:0001964) |
| 0.1 | 0.3 | GO:0051181 | cofactor transport(GO:0051181) |
| 0.1 | 0.1 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 0.1 | 0.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.1 | 0.9 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 0.1 | 1.1 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
| 0.1 | 0.4 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.1 | 0.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.1 | 0.2 | GO:0002327 | immature B cell differentiation(GO:0002327) |
| 0.1 | 0.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.1 | 0.7 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.1 | 0.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 | 0.8 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.1 | 0.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 | 0.3 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.1 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.1 | 1.3 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
| 0.1 | 3.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.1 | 3.7 | GO:0006906 | vesicle fusion(GO:0006906) |
| 0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 0.3 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.1 | 0.3 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
| 0.1 | 0.1 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 | 0.5 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.1 | 0.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.1 | 0.2 | GO:0015908 | fatty acid transport(GO:0015908) |
| 0.1 | 0.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 | 1.0 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.1 | 0.4 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.1 | 0.3 | GO:0035247 | peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.1 | 5.1 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 | 0.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 | 0.1 | GO:1900125 | regulation of hyaluronan biosynthetic process(GO:1900125) |
| 0.1 | 0.3 | GO:0050716 | regulation of interleukin-1 secretion(GO:0050704) regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.1 | 0.3 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.1 | 0.7 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 0.1 | 0.2 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 | 1.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.1 | 0.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 | 0.4 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
| 0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.1 | 0.3 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
| 0.1 | 0.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 | 3.4 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.1 | 0.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 | 0.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 | 0.1 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
| 0.1 | 0.5 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.1 | 0.3 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.1 | 1.0 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.1 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.1 | 0.4 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 0.4 | GO:0009408 | response to heat(GO:0009408) |
| 0.1 | 0.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
| 0.1 | 0.2 | GO:0071442 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 | 0.5 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 | 0.9 | GO:0009651 | response to salt stress(GO:0009651) |
| 0.1 | 3.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.1 | 1.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.1 | 0.5 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.1 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.1 | 0.1 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 0.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 3.1 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.1 | 0.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
| 0.1 | 0.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.1 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
| 0.1 | 1.0 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 | 0.3 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
| 0.1 | 0.5 | GO:1900364 | negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 | 0.4 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.1 | 0.2 | GO:1901655 | cellular response to ketone(GO:1901655) |
| 0.1 | 0.1 | GO:0046460 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.1 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 0.4 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.1 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 | 0.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.1 | 0.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 | 0.8 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
| 0.1 | 0.2 | GO:0097178 | ruffle assembly(GO:0097178) |
| 0.1 | 0.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
| 0.1 | 0.7 | GO:0042832 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
| 0.1 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 | 0.2 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 | 0.8 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
| 0.1 | 0.3 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 | 0.1 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 0.1 | 0.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
| 0.1 | 0.3 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
| 0.1 | 0.1 | GO:0002432 | granuloma formation(GO:0002432) |
| 0.1 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.1 | 0.2 | GO:0070723 | response to cholesterol(GO:0070723) |
| 0.1 | 0.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 | 0.1 | GO:0060439 | trachea morphogenesis(GO:0060439) |
| 0.1 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.1 | 0.2 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.1 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 | 1.4 | GO:0006672 | ceramide metabolic process(GO:0006672) |
| 0.1 | 0.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
| 0.1 | 0.2 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.1 | 0.5 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.1 | 0.4 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.1 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.1 | 0.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
| 0.1 | 0.2 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.1 | 0.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.1 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 | 0.6 | GO:0051788 | response to misfolded protein(GO:0051788) |
| 0.1 | 0.4 | GO:0060039 | pericardium development(GO:0060039) |
| 0.1 | 0.3 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.1 | 0.1 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.1 | 0.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
| 0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.0 | 0.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.0 | 0.0 | GO:0003192 | mitral valve formation(GO:0003192) |
| 0.0 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.0 | 0.0 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 | 0.7 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
| 0.0 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 | 0.3 | GO:0060613 | fat pad development(GO:0060613) |
| 0.0 | 0.7 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.0 | 0.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 0.0 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 0.0 | 0.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.0 | 0.3 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 | 0.3 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.0 | 0.1 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
| 0.0 | 0.1 | GO:0021764 | amygdala development(GO:0021764) |
| 0.0 | 0.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
| 0.0 | 0.2 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.0 | 0.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.0 | 0.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 | 0.1 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.0 | 2.4 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
| 0.0 | 0.2 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.0 | 0.1 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 | 0.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.0 | 0.2 | GO:1990564 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 | 0.0 | GO:0090174 | organelle membrane fusion(GO:0090174) |
| 0.0 | 0.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 | 0.7 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
| 0.0 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.0 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 | 0.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.0 | 0.3 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
| 0.0 | 0.3 | GO:0009648 | photoperiodism(GO:0009648) |
| 0.0 | 0.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.0 | 0.1 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.0 | 0.6 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.0 | 0.4 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.0 | 0.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.0 | 0.5 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
| 0.0 | 0.2 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 | 0.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 | 0.1 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
| 0.0 | 0.7 | GO:0055072 | iron ion homeostasis(GO:0055072) |
| 0.0 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
| 0.0 | 0.1 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.0 | 0.0 | GO:0099640 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) axo-dendritic protein transport(GO:0099640) |
| 0.0 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.0 | 0.1 | GO:0031113 | regulation of microtubule polymerization(GO:0031113) |
| 0.0 | 0.2 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.0 | 0.2 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.0 | 0.1 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 | 0.4 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
| 0.0 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.0 | 0.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
| 0.0 | 0.0 | GO:0000019 | regulation of mitotic recombination(GO:0000019) telomeric 3' overhang formation(GO:0031860) |
| 0.0 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
| 0.0 | 0.3 | GO:0032418 | lysosome localization(GO:0032418) |
| 0.0 | 0.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.0 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 | 0.1 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 | 0.1 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.0 | 0.2 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.0 | 0.0 | GO:0002862 | regulation of inflammatory response to antigenic stimulus(GO:0002861) negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
| 0.0 | 0.1 | GO:0031280 | negative regulation of cyclase activity(GO:0031280) |
| 0.0 | 0.0 | GO:0071220 | response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.0 | 0.5 | GO:0015992 | proton transport(GO:0015992) |
| 0.0 | 0.1 | GO:1903028 | asymmetric Golgi ribbon formation(GO:0090164) regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
| 0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.0 | 0.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
| 0.0 | 1.2 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.0 | 0.1 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.0 | 0.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.0 | 0.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 | 0.1 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
| 0.0 | 0.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.0 | 0.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 | 0.7 | GO:0007030 | Golgi organization(GO:0007030) |
| 0.0 | 0.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
| 0.0 | 0.0 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 | 0.0 | GO:0007603 | phototransduction, visible light(GO:0007603) |
| 0.0 | 0.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.0 | 0.1 | GO:0009268 | response to pH(GO:0009268) |
| 0.0 | 0.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.0 | 0.0 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.7 | 23.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 4.5 | 27.1 | GO:0008091 | spectrin(GO:0008091) |
| 3.4 | 10.2 | GO:0098830 | presynaptic endosome(GO:0098830) |
| 3.3 | 13.3 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 2.4 | 16.8 | GO:0070695 | FHF complex(GO:0070695) |
| 2.4 | 9.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 2.4 | 9.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 2.0 | 6.1 | GO:0072534 | perineuronal net(GO:0072534) |
| 1.9 | 9.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
| 1.9 | 5.8 | GO:0044194 | cytolytic granule(GO:0044194) |
| 1.9 | 28.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 1.9 | 5.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 1.9 | 24.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 1.8 | 8.8 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 1.7 | 6.8 | GO:0044307 | dendritic branch(GO:0044307) |
| 1.7 | 6.8 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 1.6 | 8.1 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 1.5 | 29.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 1.5 | 7.6 | GO:1990037 | Lewy body core(GO:1990037) |
| 1.5 | 31.0 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 1.4 | 4.3 | GO:0098855 | HCN channel complex(GO:0098855) |
| 1.4 | 4.2 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 1.4 | 4.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 1.3 | 21.4 | GO:0043196 | varicosity(GO:0043196) |
| 1.3 | 14.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 1.3 | 6.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 1.3 | 5.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 1.3 | 5.3 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
| 1.3 | 3.8 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 1.3 | 2.6 | GO:0043083 | synaptic cleft(GO:0043083) |
| 1.3 | 11.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 1.3 | 1.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 1.3 | 7.5 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 1.2 | 27.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 1.2 | 3.7 | GO:0043512 | inhibin A complex(GO:0043512) |
| 1.2 | 34.3 | GO:0033268 | node of Ranvier(GO:0033268) |
| 1.2 | 10.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 1.2 | 12.8 | GO:0032426 | stereocilium tip(GO:0032426) |
| 1.1 | 11.5 | GO:0045298 | tubulin complex(GO:0045298) |
| 1.1 | 4.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 1.0 | 15.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 1.0 | 1.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 1.0 | 10.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 1.0 | 2.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 1.0 | 4.1 | GO:0097441 | basilar dendrite(GO:0097441) |
| 1.0 | 7.0 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
| 1.0 | 2.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 1.0 | 5.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 1.0 | 4.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 1.0 | 37.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
| 1.0 | 4.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 1.0 | 3.9 | GO:0031983 | vesicle lumen(GO:0031983) |
| 0.9 | 10.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.9 | 2.7 | GO:0005927 | muscle tendon junction(GO:0005927) cuticular plate(GO:0032437) |
| 0.8 | 2.5 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.8 | 2.4 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.8 | 11.2 | GO:0097449 | astrocyte projection(GO:0097449) |
| 0.8 | 1.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.8 | 3.1 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.8 | 12.2 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.8 | 3.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.8 | 3.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.8 | 9.1 | GO:0043203 | axon hillock(GO:0043203) |
| 0.8 | 1.5 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.7 | 2.9 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
| 0.7 | 2.1 | GO:0002141 | stereocilia ankle link(GO:0002141) |
| 0.7 | 11.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.7 | 3.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.7 | 2.0 | GO:0042581 | specific granule(GO:0042581) |
| 0.7 | 0.7 | GO:0019034 | viral replication complex(GO:0019034) |
| 0.6 | 3.9 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.6 | 3.2 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.6 | 1.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.6 | 5.7 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.6 | 5.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.6 | 1.3 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.6 | 4.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.6 | 8.0 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.6 | 3.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.6 | 7.9 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.6 | 5.9 | GO:0030673 | axolemma(GO:0030673) |
| 0.6 | 18.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.6 | 24.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.6 | 16.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.6 | 3.9 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.6 | 1.1 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.6 | 37.8 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.5 | 8.7 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
| 0.5 | 20.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.5 | 6.0 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.5 | 2.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.5 | 2.1 | GO:0097227 | sperm annulus(GO:0097227) |
| 0.5 | 2.1 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.5 | 1.6 | GO:0005940 | septin ring(GO:0005940) |
| 0.5 | 42.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.5 | 16.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.5 | 2.5 | GO:0031045 | dense core granule(GO:0031045) |
| 0.5 | 1.5 | GO:0034657 | GID complex(GO:0034657) |
| 0.5 | 3.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.5 | 3.9 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.5 | 0.5 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) endocytic vesicle membrane(GO:0030666) clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.5 | 0.5 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.5 | 0.9 | GO:0030315 | T-tubule(GO:0030315) |
| 0.5 | 9.6 | GO:0031430 | M band(GO:0031430) |
| 0.5 | 9.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.5 | 7.3 | GO:0000145 | exocyst(GO:0000145) |
| 0.4 | 2.2 | GO:0097361 | CIA complex(GO:0097361) |
| 0.4 | 3.5 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.4 | 11.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.4 | 2.1 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.4 | 10.3 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.4 | 2.9 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.4 | 1.2 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.4 | 5.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.4 | 75.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.4 | 4.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.4 | 2.7 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.4 | 5.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.3 | 1.7 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.3 | 1.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 0.3 | 21.2 | GO:0005604 | basement membrane(GO:0005604) |
| 0.3 | 9.4 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.3 | 1.0 | GO:0042599 | lamellar body(GO:0042599) |
| 0.3 | 1.3 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
| 0.3 | 0.3 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.3 | 32.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.3 | 1.6 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.3 | 13.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.3 | 3.1 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
| 0.3 | 2.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.3 | 1.2 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.3 | 11.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.3 | 1.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
| 0.3 | 2.8 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.3 | 3.4 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
| 0.3 | 3.3 | GO:0044754 | autolysosome(GO:0044754) |
| 0.3 | 0.9 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.3 | 1.5 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
| 0.3 | 5.0 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.3 | 1.5 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.3 | 6.7 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.3 | 0.3 | GO:0071010 | prespliceosome(GO:0071010) |
| 0.3 | 0.9 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.3 | 0.9 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.3 | 26.6 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.3 | 17.7 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.3 | 1.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.3 | 0.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.3 | 2.2 | GO:0002177 | manchette(GO:0002177) |
| 0.3 | 0.8 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.3 | 1.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.3 | 1.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.3 | 5.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.3 | 4.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.3 | 1.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.3 | 2.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.3 | 1.0 | GO:0001651 | dense fibrillar component(GO:0001651) |
| 0.3 | 1.3 | GO:1990745 | EARP complex(GO:1990745) |
| 0.3 | 2.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.3 | 1.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.3 | 1.0 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.3 | 1.5 | GO:1990393 | 3M complex(GO:1990393) |
| 0.3 | 4.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.3 | 0.5 | GO:0044299 | C-fiber(GO:0044299) |
| 0.2 | 1.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.2 | 3.2 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.2 | 1.2 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 0.2 | 4.9 | GO:0030139 | endocytic vesicle(GO:0030139) |
| 0.2 | 1.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.2 | 3.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.2 | 2.5 | GO:0031672 | A band(GO:0031672) |
| 0.2 | 1.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.2 | 0.7 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.2 | 0.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.2 | 0.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.2 | 1.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.2 | 0.9 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.2 | 1.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.2 | 1.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 28.2 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.2 | 2.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.2 | 1.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.2 | 1.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.2 | 3.0 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.2 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.2 | 0.6 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.2 | 4.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.2 | 0.4 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 0.2 | 35.4 | GO:0005769 | early endosome(GO:0005769) |
| 0.2 | 1.8 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.2 | 1.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.2 | 4.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.2 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.2 | 0.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.2 | 1.6 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.2 | 0.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.2 | 16.4 | GO:0031256 | leading edge membrane(GO:0031256) |
| 0.2 | 3.8 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.2 | 2.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.2 | 4.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.2 | 6.2 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.2 | 3.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.2 | 3.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.2 | 4.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.2 | 1.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.2 | 1.0 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.2 | 0.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.2 | 1.0 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.2 | 1.7 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.2 | 0.5 | GO:0071437 | invadopodium(GO:0071437) |
| 0.2 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.2 | 1.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.2 | 0.7 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.2 | 0.5 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.2 | 1.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
| 0.2 | 2.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.2 | 0.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.2 | 3.8 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.2 | 2.1 | GO:0031253 | cell projection membrane(GO:0031253) |
| 0.1 | 0.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.1 | 0.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.1 | 0.7 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.1 | 5.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 0.8 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.1 | 1.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.1 | 0.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.1 | 0.3 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.1 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.1 | 0.7 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.1 | 7.7 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 0.6 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.1 | 0.6 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 1.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 24.6 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.1 | 1.6 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 3.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.1 | 1.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.1 | 0.8 | GO:0005638 | lamin filament(GO:0005638) |
| 0.1 | 2.0 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 0.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.1 | 0.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
| 0.1 | 0.8 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.1 | 0.9 | GO:0042641 | actomyosin(GO:0042641) |
| 0.1 | 2.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.1 | 3.7 | GO:0012506 | vesicle membrane(GO:0012506) |
| 0.1 | 6.3 | GO:0005770 | late endosome(GO:0005770) |
| 0.1 | 1.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.1 | 0.3 | GO:0070985 | TFIIK complex(GO:0070985) |
| 0.1 | 3.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 0.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.1 | 0.9 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.1 | 0.7 | GO:0034704 | calcium channel complex(GO:0034704) |
| 0.1 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.1 | 0.3 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.1 | 4.2 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 0.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 7.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.1 | 1.9 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 3.8 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.1 | 0.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 1.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.1 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 8.2 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
| 0.1 | 46.4 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
| 0.1 | 1.4 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 5.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 4.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.1 | 6.5 | GO:0098791 | trans-Golgi network(GO:0005802) Golgi subcompartment(GO:0098791) |
| 0.1 | 0.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.1 | 2.7 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 0.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 0.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.1 | 1.5 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
| 0.1 | 1.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 2.1 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.1 | 0.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.1 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 1.1 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 0.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.1 | 0.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.1 | 4.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.1 | 0.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 0.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
| 0.1 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.1 | 0.3 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.0 | 0.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.0 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 1.1 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.0 | 0.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.0 | 10.1 | GO:0005768 | endosome(GO:0005768) |
| 0.0 | 0.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.0 | 0.6 | GO:0043235 | receptor complex(GO:0043235) |
| 0.0 | 0.3 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.0 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.0 | 0.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.0 | 0.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.0 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 1.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 1.1 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.0 | 1.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 79.6 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
| 0.0 | 1.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
| 0.0 | 0.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.0 | 0.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.0 | 0.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.0 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.0 | 0.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 0.7 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 0.9 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.0 | 0.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
| 0.0 | 0.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.0 | 0.0 | GO:0071920 | cleavage body(GO:0071920) |
| 0.0 | 0.1 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
| 0.0 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.5 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.0 | 0.3 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.0 | 0.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.0 | 7.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 6.2 | 18.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 5.0 | 34.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 3.4 | 23.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 3.3 | 23.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 3.2 | 16.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 3.2 | 9.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 3.1 | 9.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 2.7 | 10.9 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 2.6 | 30.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 2.5 | 10.1 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
| 2.5 | 7.4 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 2.3 | 25.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 2.3 | 9.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 2.3 | 9.1 | GO:0001639 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
| 2.2 | 6.5 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 2.1 | 6.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 2.0 | 8.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 1.9 | 9.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 1.8 | 9.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 1.8 | 11.0 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 1.8 | 7.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 1.8 | 7.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 1.8 | 5.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 1.7 | 12.2 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 1.7 | 5.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 1.7 | 6.6 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 1.7 | 18.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 1.6 | 3.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 1.6 | 4.9 | GO:0008527 | taste receptor activity(GO:0008527) |
| 1.6 | 8.1 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 1.6 | 12.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 1.6 | 14.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 1.6 | 17.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 1.6 | 4.7 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 1.6 | 15.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 1.6 | 18.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 1.5 | 4.6 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
| 1.5 | 5.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 1.5 | 4.4 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 1.5 | 10.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 1.5 | 5.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 1.4 | 11.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 1.4 | 7.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 1.4 | 15.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 1.4 | 4.1 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 1.4 | 4.1 | GO:0046911 | hydroxyapatite binding(GO:0046848) metal chelating activity(GO:0046911) phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 1.4 | 5.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
| 1.3 | 8.0 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 1.3 | 5.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 1.3 | 7.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 1.3 | 15.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 1.2 | 3.7 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 1.2 | 3.6 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 1.2 | 3.6 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
| 1.2 | 4.8 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 1.2 | 4.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 1.2 | 6.9 | GO:0033691 | sialic acid binding(GO:0033691) |
| 1.2 | 4.6 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
| 1.1 | 6.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 1.1 | 3.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 1.1 | 2.2 | GO:0004103 | choline kinase activity(GO:0004103) |
| 1.1 | 4.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 1.1 | 9.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) phosphofructokinase activity(GO:0008443) |
| 1.1 | 4.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 1.1 | 24.6 | GO:0030506 | ankyrin binding(GO:0030506) |
| 1.1 | 13.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 1.1 | 3.2 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 1.0 | 6.3 | GO:0019864 | immunoglobulin receptor activity(GO:0019763) IgG binding(GO:0019864) |
| 1.0 | 6.0 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
| 1.0 | 39.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 1.0 | 5.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 1.0 | 3.0 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 1.0 | 20.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 1.0 | 2.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 1.0 | 1.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 1.0 | 3.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 1.0 | 1.0 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 1.0 | 3.8 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.9 | 11.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.9 | 8.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.9 | 2.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.9 | 14.0 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
| 0.9 | 2.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.9 | 3.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.9 | 4.5 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.9 | 12.6 | GO:0031005 | filamin binding(GO:0031005) |
| 0.9 | 17.0 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.9 | 5.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.9 | 14.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.9 | 3.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.9 | 9.5 | GO:0019531 | secondary active sulfate transmembrane transporter activity(GO:0008271) oxalate transmembrane transporter activity(GO:0019531) |
| 0.9 | 5.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.9 | 4.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.9 | 3.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.9 | 11.1 | GO:0005522 | profilin binding(GO:0005522) |
| 0.9 | 6.8 | GO:0036122 | BMP binding(GO:0036122) |
| 0.8 | 0.8 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.8 | 11.5 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.8 | 4.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.8 | 3.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.8 | 3.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.8 | 13.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.8 | 7.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.8 | 6.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.7 | 2.2 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 0.7 | 18.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.7 | 3.0 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.7 | 22.2 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.7 | 2.2 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
| 0.7 | 4.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.7 | 1.4 | GO:0019863 | IgE binding(GO:0019863) |
| 0.7 | 5.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.7 | 2.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.7 | 2.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.7 | 2.8 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.7 | 0.7 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.7 | 4.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.7 | 8.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.7 | 5.5 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 0.7 | 2.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 0.7 | 2.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.6 | 3.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.6 | 3.9 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.6 | 3.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.6 | 6.9 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.6 | 1.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.6 | 1.9 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.6 | 0.6 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.6 | 1.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.6 | 5.5 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
| 0.6 | 6.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.6 | 1.8 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.6 | 1.8 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.6 | 21.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.6 | 4.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.6 | 0.6 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.6 | 1.7 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.6 | 2.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.6 | 1.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.6 | 4.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.6 | 2.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.6 | 4.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.6 | 3.4 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 0.6 | 1.7 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.6 | 22.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.6 | 7.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.6 | 8.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.6 | 2.2 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
| 0.5 | 7.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.5 | 2.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.5 | 2.7 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.5 | 1.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.5 | 8.0 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
| 0.5 | 2.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.5 | 28.9 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.5 | 1.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.5 | 1.6 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.5 | 4.7 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
| 0.5 | 2.6 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.5 | 6.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.5 | 0.5 | GO:0005168 | neurotrophin TRK receptor binding(GO:0005167) neurotrophin TRKA receptor binding(GO:0005168) |
| 0.5 | 2.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.5 | 0.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.5 | 6.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.5 | 3.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.5 | 3.0 | GO:0016917 | GABA receptor activity(GO:0016917) |
| 0.5 | 2.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.5 | 6.8 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.5 | 1.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.5 | 3.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.5 | 1.9 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.5 | 13.5 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.5 | 16.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.5 | 1.8 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
| 0.5 | 12.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.5 | 6.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.5 | 1.4 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.5 | 1.4 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
| 0.5 | 2.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.5 | 2.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.5 | 3.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.5 | 1.4 | GO:0031403 | lithium ion binding(GO:0031403) |
| 0.5 | 3.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
| 0.5 | 18.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.4 | 0.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.4 | 13.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.4 | 1.3 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.4 | 5.7 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.4 | 3.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.4 | 0.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.4 | 1.7 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.4 | 5.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.4 | 2.1 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) |
| 0.4 | 2.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.4 | 5.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.4 | 2.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.4 | 11.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.4 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
| 0.4 | 1.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.4 | 6.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.4 | 6.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.4 | 9.0 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.4 | 4.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.4 | 0.8 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
| 0.4 | 1.5 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.4 | 4.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.4 | 1.5 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
| 0.4 | 1.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.4 | 11.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.4 | 1.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.4 | 0.7 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.4 | 2.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.4 | 2.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.4 | 1.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.4 | 10.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.4 | 15.8 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.4 | 7.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.3 | 4.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.3 | 0.7 | GO:0030519 | snoRNP binding(GO:0030519) |
| 0.3 | 1.7 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.3 | 1.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
| 0.3 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.3 | 2.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.3 | 2.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.3 | 2.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.3 | 2.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.3 | 1.0 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.3 | 20.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.3 | 1.3 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.3 | 1.3 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
| 0.3 | 2.2 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.3 | 1.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.3 | 1.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.3 | 1.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.3 | 4.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
| 0.3 | 1.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.3 | 1.2 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.3 | 1.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.3 | 0.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.3 | 5.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.3 | 3.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.3 | 0.9 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
| 0.3 | 5.4 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.3 | 0.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.3 | 0.9 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.3 | 5.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.3 | 5.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.3 | 7.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.3 | 2.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.3 | 0.6 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.3 | 0.9 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.3 | 0.6 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
| 0.3 | 0.9 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.3 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.3 | 0.9 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
| 0.3 | 13.2 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.3 | 1.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.3 | 2.8 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.3 | 2.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.3 | 16.0 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.3 | 1.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.3 | 3.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.3 | 0.5 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
| 0.3 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.3 | 4.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.3 | 1.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.3 | 8.7 | GO:0005112 | Notch binding(GO:0005112) |
| 0.3 | 1.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.3 | 6.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.2 | 5.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.2 | 1.2 | GO:0089720 | caspase binding(GO:0089720) |
| 0.2 | 2.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.2 | 1.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.2 | 0.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.2 | 1.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.2 | 0.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.2 | 1.7 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
| 0.2 | 0.7 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.2 | 1.9 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.2 | 6.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.2 | 0.2 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
| 0.2 | 1.2 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.2 | 0.9 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.2 | 1.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.2 | 15.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.2 | 0.7 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
| 0.2 | 1.6 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.2 | 0.7 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.2 | 1.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.2 | 5.2 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.2 | 0.5 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.2 | 2.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.2 | 0.7 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.2 | 1.6 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.2 | 2.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
| 0.2 | 20.8 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.2 | 2.0 | GO:0005521 | lamin binding(GO:0005521) |
| 0.2 | 6.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.2 | 1.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.2 | 0.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.2 | 1.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.2 | 1.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.2 | 0.9 | GO:0008061 | chitin binding(GO:0008061) |
| 0.2 | 0.6 | GO:0016151 | nickel cation binding(GO:0016151) |
| 0.2 | 1.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.2 | 0.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.2 | 4.7 | GO:0042805 | actinin binding(GO:0042805) |
| 0.2 | 3.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.2 | 1.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.2 | 0.8 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.2 | 3.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.2 | 1.7 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.2 | 1.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.2 | 0.6 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.2 | 1.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.2 | 0.6 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
| 0.2 | 1.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.2 | 1.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.2 | 6.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.2 | 1.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.2 | 1.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.2 | 0.4 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.2 | 3.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.2 | 4.0 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.2 | 0.4 | GO:0036004 | GAF domain binding(GO:0036004) |
| 0.2 | 1.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.2 | 0.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.2 | 2.6 | GO:0004629 | phospholipase C activity(GO:0004629) |
| 0.2 | 0.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.2 | 1.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.2 | 0.2 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
| 0.2 | 0.9 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.2 | 2.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.2 | 0.7 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.2 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.2 | 0.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.2 | 1.5 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) sodium:proton antiporter activity(GO:0015385) |
| 0.2 | 2.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.2 | 1.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 0.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.2 | 0.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.2 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.2 | 1.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.2 | 1.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.2 | 2.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.2 | 0.5 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.2 | 4.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.2 | 0.5 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.2 | 1.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.2 | 1.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.2 | 0.3 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.2 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.2 | 10.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.2 | 3.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.2 | 4.0 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.2 | 0.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.2 | 0.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.2 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.2 | 0.8 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.2 | 1.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.2 | 2.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.2 | 0.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.2 | 1.0 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.2 | 0.5 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.2 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
| 0.2 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.2 | 1.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.2 | 0.5 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
| 0.2 | 2.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.2 | 0.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
| 0.2 | 1.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.2 | 3.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 0.4 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.1 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.1 | 0.4 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
| 0.1 | 3.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.1 | 1.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.1 | 5.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.1 | 1.3 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 2.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 4.3 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 0.6 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.1 | 0.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.1 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 3.5 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.1 | 0.6 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.1 | 2.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 12.6 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.1 | 0.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 0.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
| 0.1 | 0.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.1 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.1 | 6.7 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.1 | 1.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.1 | 0.5 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.1 | 1.0 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.1 | 34.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.1 | 0.5 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 0.4 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
| 0.1 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.1 | 0.4 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.1 | 0.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.1 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.1 | 5.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.1 | 1.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 0.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.1 | 1.7 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.1 | 0.6 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 0.5 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
| 0.1 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.1 | 2.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.1 | 0.9 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.1 | 2.4 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
| 0.1 | 4.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.1 | 0.5 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.1 | 1.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 0.6 | GO:0004043 | L-aminoadipate-semialdehyde dehydrogenase activity(GO:0004043) |
| 0.1 | 0.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.1 | 0.4 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.1 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.1 | 2.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.1 | 1.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.1 | 1.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 0.3 | GO:0043559 | apolipoprotein A-I binding(GO:0034186) insulin binding(GO:0043559) |
| 0.1 | 0.9 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.1 | 5.7 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.1 | 2.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 0.5 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.1 | 0.6 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
| 0.1 | 0.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.1 | 0.4 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.1 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.1 | 1.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 1.6 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.1 | 1.6 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.1 | 0.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.1 | 0.3 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.1 | 0.3 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.1 | 0.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.1 | 0.7 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
| 0.1 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.1 | 0.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.1 | 3.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 0.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.1 | 1.6 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.1 | 5.4 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.1 | 0.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.1 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.1 | 0.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 0.3 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.1 | 0.1 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
| 0.1 | 0.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 0.4 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
| 0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.1 | 0.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.1 | 1.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 0.1 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
| 0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.1 | 0.9 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.1 | 3.5 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.1 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.1 | 4.9 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
| 0.1 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
| 0.1 | 0.9 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.1 | 0.4 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.1 | 0.3 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.1 | 0.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.1 | 0.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.1 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 12.8 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 1.4 | GO:0015297 | antiporter activity(GO:0015297) |
| 0.1 | 0.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 0.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.1 | 3.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.1 | 0.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.1 | 0.2 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.1 | 0.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.0 | 0.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.0 | 0.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.0 | 1.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 0.2 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.0 | 18.9 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 0.1 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.0 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.0 | 0.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
| 0.0 | 0.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.0 | 0.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.0 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.0 | 0.1 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.0 | 0.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.0 | 0.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
| 0.0 | 2.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 0.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.0 | 0.6 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.0 | 0.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.0 | 0.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 0.0 | 1.0 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.0 | 0.1 | GO:0023023 | MHC protein complex binding(GO:0023023) |
| 0.0 | 0.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.0 | 0.9 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.0 | 0.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.0 | 1.1 | GO:0016209 | antioxidant activity(GO:0016209) |
| 0.0 | 0.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.0 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.0 | 0.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.0 | 1.2 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
| 0.0 | 0.3 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.0 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.0 | 1.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
| 0.0 | 0.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.0 | 1.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.0 | 0.1 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.0 | 4.2 | GO:0003779 | actin binding(GO:0003779) |
| 0.0 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
| 0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.0 | 1.8 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
| 0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.0 | 0.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.0 | 0.1 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.0 | 0.0 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 0.0 | 0.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.0 | 0.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 2.6 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 1.2 | 19.6 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
| 1.0 | 70.1 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
| 0.8 | 0.8 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.7 | 1.5 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.6 | 6.3 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.6 | 26.1 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
| 0.6 | 6.0 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.6 | 29.3 | PID_REELIN_PATHWAY | Reelin signaling pathway |
| 0.6 | 20.0 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.6 | 31.3 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
| 0.5 | 19.3 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
| 0.5 | 7.3 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 0.5 | 17.7 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.5 | 11.8 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.5 | 6.3 | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.5 | 0.5 | ST_INTERFERON_GAMMA_PATHWAY | Interferon gamma pathway. |
| 0.5 | 24.5 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.5 | 3.7 | PID_LYMPH_ANGIOGENESIS_PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.4 | 5.8 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
| 0.4 | 2.2 | PID_EPO_PATHWAY | EPO signaling pathway |
| 0.4 | 0.9 | ST_IL_13_PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.4 | 7.8 | PID_INTEGRIN_A4B1_PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.4 | 5.3 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.4 | 6.7 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.4 | 5.5 | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.4 | 2.0 | PID_FOXO_PATHWAY | FoxO family signaling |
| 0.4 | 10.1 | ST_GA12_PATHWAY | G alpha 12 Pathway |
| 0.4 | 4.6 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
| 0.4 | 1.9 | PID_S1P_S1P1_PATHWAY | S1P1 pathway |
| 0.4 | 26.7 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
| 0.4 | 1.9 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
| 0.4 | 6.7 | PID_KIT_PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.4 | 10.0 | PID_ARF_3PATHWAY | Arf1 pathway |
| 0.4 | 16.6 | PID_TRKR_PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.4 | 1.1 | PID_ENDOTHELIN_PATHWAY | Endothelins |
| 0.4 | 6.9 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.3 | 3.8 | PID_RHODOPSIN_PATHWAY | Visual signal transduction: Rods |
| 0.3 | 2.8 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
| 0.3 | 9.8 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
| 0.3 | 1.6 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.3 | 8.7 | SIG_CHEMOTAXIS | Genes related to chemotaxis |
| 0.3 | 11.0 | PID_INSULIN_PATHWAY | Insulin Pathway |
| 0.3 | 53.0 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
| 0.3 | 5.5 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.3 | 6.1 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.3 | 6.5 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.3 | 4.2 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
| 0.3 | 6.2 | PID_ERBB1_DOWNSTREAM_PATHWAY | ErbB1 downstream signaling |
| 0.2 | 0.5 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.2 | 6.0 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
| 0.2 | 3.4 | PID_IL2_1PATHWAY | IL2-mediated signaling events |
| 0.2 | 24.9 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.2 | 0.8 | ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY | PI3K Pathway |
| 0.2 | 4.3 | PID_TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.2 | 12.2 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
| 0.2 | 1.0 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.2 | 1.3 | PID_PTP1B_PATHWAY | Signaling events mediated by PTP1B |
| 0.2 | 6.0 | PID_ATF2_PATHWAY | ATF-2 transcription factor network |
| 0.2 | 7.4 | PID_AP1_PATHWAY | AP-1 transcription factor network |
| 0.2 | 4.8 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 0.9 | PID_ER_NONGENOMIC_PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 0.8 | PID_SHP2_PATHWAY | SHP2 signaling |
| 0.1 | 4.3 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
| 0.1 | 3.5 | PID_BCR_5PATHWAY | BCR signaling pathway |
| 0.1 | 0.8 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
| 0.1 | 0.8 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
| 0.1 | 1.1 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 2.3 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 1.4 | PID_RHOA_PATHWAY | RhoA signaling pathway |
| 0.1 | 3.4 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 5.8 | PID_BETA_CATENIN_NUC_PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 1.5 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
| 0.1 | 2.8 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 0.5 | PID_ALK2_PATHWAY | ALK2 signaling events |
| 0.1 | 1.3 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 2.1 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
| 0.1 | 3.0 | PID_LKB1_PATHWAY | LKB1 signaling events |
| 0.1 | 1.2 | PID_NFAT_TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 0.5 | PID_IL2_PI3K_PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 0.9 | PID_TRAIL_PATHWAY | TRAIL signaling pathway |
| 0.1 | 0.6 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.0 | 0.6 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
| 0.0 | 1.9 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 0.3 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
| 0.0 | 0.1 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
| 0.0 | 0.2 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
| 0.0 | 0.6 | PID_P53_DOWNSTREAM_PATHWAY | Direct p53 effectors |
| 0.0 | 0.1 | PID_IFNG_PATHWAY | IFN-gamma pathway |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.1 | 18.5 | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 2.3 | 45.3 | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 1.8 | 40.6 | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 1.7 | 27.8 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
| 1.7 | 12.1 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 1.7 | 22.2 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 1.6 | 9.5 | REACTOME_COMMON_PATHWAY | Genes involved in Common Pathway |
| 1.4 | 37.7 | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | Genes involved in DCC mediated attractive signaling |
| 1.4 | 4.1 | REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
| 1.4 | 13.6 | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 1.3 | 2.6 | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 1.3 | 45.4 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 1.2 | 4.7 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
| 1.0 | 8.3 | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | Genes involved in Transport of organic anions |
| 1.0 | 12.9 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.9 | 3.7 | REACTOME_GLYCOPROTEIN_HORMONES | Genes involved in Glycoprotein hormones |
| 0.9 | 0.9 | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | Genes involved in Post NMDA receptor activation events |
| 0.9 | 3.5 | REACTOME_REGULATION_OF_INSULIN_SECRETION | Genes involved in Regulation of Insulin Secretion |
| 0.9 | 32.4 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.8 | 10.9 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.8 | 10.7 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.8 | 26.1 | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.8 | 10.0 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
| 0.7 | 9.6 | REACTOME_ACTIVATION_OF_RAC | Genes involved in Activation of Rac |
| 0.7 | 7.4 | REACTOME_CA_DEPENDENT_EVENTS | Genes involved in Ca-dependent events |
| 0.7 | 7.9 | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.7 | 10.5 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
| 0.7 | 17.5 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
| 0.7 | 14.7 | REACTOME_INSULIN_RECEPTOR_RECYCLING | Genes involved in Insulin receptor recycling |
| 0.7 | 14.5 | REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.6 | 19.5 | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.6 | 21.2 | REACTOME_SYNTHESIS_OF_PA | Genes involved in Synthesis of PA |
| 0.6 | 8.3 | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.6 | 11.6 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.6 | 4.0 | REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.6 | 5.6 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.6 | 3.9 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.5 | 20.9 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.5 | 5.9 | REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.5 | 22.8 | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
| 0.5 | 11.3 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.5 | 3.0 | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.5 | 3.0 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
| 0.5 | 18.3 | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.4 | 10.5 | REACTOME_ACTIVATION_OF_GENES_BY_ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.4 | 7.0 | REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.4 | 3.4 | REACTOME_POTASSIUM_CHANNELS | Genes involved in Potassium Channels |
| 0.4 | 2.5 | REACTOME_SIGNALLING_TO_RAS | Genes involved in Signalling to RAS |
| 0.4 | 9.7 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
| 0.4 | 9.5 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.4 | 9.1 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.4 | 3.2 | REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.4 | 7.5 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.4 | 7.9 | REACTOME_IL_3_5_AND_GM_CSF_SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
| 0.4 | 0.4 | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.4 | 7.9 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
| 0.4 | 10.0 | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.3 | 12.2 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.3 | 1.0 | REACTOME_PERK_REGULATED_GENE_EXPRESSION | Genes involved in PERK regulated gene expression |
| 0.3 | 1.0 | REACTOME_ARMS_MEDIATED_ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.3 | 4.9 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.3 | 5.2 | REACTOME_PURINE_SALVAGE | Genes involved in Purine salvage |
| 0.3 | 1.5 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
| 0.3 | 0.9 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
| 0.3 | 0.9 | REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.3 | 4.5 | REACTOME_SIGNALING_BY_NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 0.3 | 4.7 | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.3 | 1.1 | REACTOME_ANDROGEN_BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.3 | 0.5 | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.3 | 11.6 | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.3 | 2.7 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.3 | 6.1 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.3 | 2.6 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.3 | 1.3 | REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.3 | 9.7 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.3 | 0.5 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
| 0.3 | 0.5 | REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.2 | 3.0 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.2 | 4.1 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.2 | 8.7 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
| 0.2 | 3.6 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.2 | 1.3 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.2 | 1.5 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
| 0.2 | 1.3 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
| 0.2 | 2.9 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.2 | 0.6 | REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.2 | 2.8 | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.2 | 3.6 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.2 | 2.9 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.2 | 1.3 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 0.2 | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.2 | 2.1 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.2 | 28.8 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.2 | 7.5 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.2 | 2.2 | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.2 | 1.2 | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.2 | 3.4 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.2 | 3.4 | REACTOME_RNA_POL_III_CHAIN_ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.2 | 1.1 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.2 | 0.8 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PS | Genes involved in Acyl chain remodelling of PS |
| 0.1 | 2.2 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.1 | 4.9 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 2.0 | REACTOME_CS_DS_DEGRADATION | Genes involved in CS/DS degradation |
| 0.1 | 0.8 | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 5.3 | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 3.0 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 0.5 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.1 | 0.5 | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.1 | 3.5 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 0.6 | REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.1 | 1.4 | REACTOME_INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.1 | 0.7 | REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 1.2 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 1.4 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 1.9 | REACTOME_GAP_JUNCTION_TRAFFICKING | Genes involved in Gap junction trafficking |
| 0.1 | 2.3 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 1.1 | REACTOME_PROTEIN_FOLDING | Genes involved in Protein folding |
| 0.1 | 3.0 | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.1 | 0.9 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.1 | 0.4 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 1.0 | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 2.7 | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
| 0.1 | 0.2 | REACTOME_SIGNALING_BY_FGFR3_MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.1 | 0.8 | REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.1 | 1.1 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.1 | 0.5 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.1 | 0.8 | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.1 | 1.6 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 3.0 | REACTOME_SIGNALING_BY_ERBB2 | Genes involved in Signaling by ERBB2 |
| 0.1 | 1.9 | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.1 | 0.1 | REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.1 | 3.4 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 1.1 | REACTOME_INTERFERON_GAMMA_SIGNALING | Genes involved in Interferon gamma signaling |
| 0.1 | 1.2 | REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.1 | 0.9 | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 1.3 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.1 | 3.3 | REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.1 | 2.9 | REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.0 | 0.4 | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.0 | 0.3 | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | Genes involved in G alpha (z) signalling events |
| 0.0 | 0.3 | REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.0 | 2.0 | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | Genes involved in G alpha (s) signalling events |
| 0.0 | 0.4 | REACTOME_HYALURONAN_METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.0 | 0.4 | REACTOME_MTORC1_MEDIATED_SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.0 | 0.3 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.0 | 0.7 | REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.0 | 0.4 | REACTOME_IL1_SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 0.2 | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 0.7 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.7 | REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
| 0.0 | 0.3 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.0 | 0.2 | REACTOME_IRON_UPTAKE_AND_TRANSPORT | Genes involved in Iron uptake and transport |
| 0.0 | 0.2 | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.0 | 0.2 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.0 | 0.2 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 0.1 | REACTOME_MRNA_CAPPING | Genes involved in mRNA Capping |
| 0.0 | 0.1 | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.0 | 0.1 | REACTOME_FRS2_MEDIATED_CASCADE | Genes involved in FRS2-mediated cascade |
|
|
|